Cargando…
Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
The DENV envelope (E) and pre-membrane (prM) glycoproteins are primary targets of serologic immunity after infection and vaccination. Of these, serotype-specific (TS) antibodies typically target E domains, while serotype cross-reactive (CR) antibodies typically the target prM protein and conserved E...
Autores principales: | Zhu, Deanna R., Rajesh, Alecia J., Meganck, Rita M., Young, Ellen F., Munt, Jennifer E., Tse, Victor L., Yount, Boyd, Conrad, Helen, White, Laura, Henein, Sandra, DeSilva, Aravinda M., Baric, Ralph S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653845/ https://www.ncbi.nlm.nih.gov/pubmed/37800919 http://dx.doi.org/10.1128/mbio.00818-23 |
Ejemplares similares
-
A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity
por: Young, Ellen, et al.
Publicado: (2023) -
Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes
por: Gallichotte, Emily N., et al.
Publicado: (2018) -
Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees
por: Martinez, David R., et al.
Publicado: (2020) -
Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone
por: Gallichotte, Emily N., et al.
Publicado: (2017) -
Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
por: White, Laura J., et al.
Publicado: (2021)